Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04385134
Other study ID # Bayichildren's-02
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 20, 2020
Est. completion date December 25, 2022

Study information

Verified date May 2020
Source Bayi Children's Hospital Affiliated to PLA Army General Hospital, China
Contact Zhichun Feng, Prof
Phone +86(10) 66721786
Email fengzhichun81@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Neonates could be infected by non-polio enterovirus easily. Some of the neonates may develop fatal complications within one week. The objective of this study were as following: 1.To understand the composition and epidemiological characteristics of enterovirus infection in pregnant women in some areas of China; 2.To understand the transmission from mother to their neonates; 3.To understand the pathogenic spectrum composition, epidemiological characteristics and clinical characteristics of enterovirus infection in neonates; 4.To understand the genetic variation and changes of enteroviruses; 5.To establish a quality management system for maternal and neonatal enterovirus laboratory testing and monitoring.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 6500
Est. completion date December 25, 2022
Est. primary completion date May 20, 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 60 Years
Eligibility Inclusion Criteria:

- 1. General parturient: on the first day of the third week of each month, all parturients and their newborns admitted to the hospital (day shift 8:00-18:00) within that day; 2. Puerpera with fever: all puerperas with fever (body temperature >=37.5 degree C) and their newborns were included in summer and autumn (from May); 3. Febrile newborns: those included in summer and autumn (from May) with the following clinical characteristics: fever >=37.5 degree C, lasting for more than one day. And sign the informed consent form with the consent of the guardian.

Exclusion Criteria:

- 1. Pregnant women with urinary tract infection, chorioamnionitis and bacterial infection; 2. Puerpera with fever due to urinary tract infection, chorioamnionitis and bacterial infection; 3. Newborns infected with other pathogens.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
China Bayi Children's Hospital, Seventh Medical Center, PLA general hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Bayi Children's Hospital Affiliated to PLA Army General Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detection of enterovirus Detection of the rate of enterovirus infection and identify the genotype of enterovirus. 42 days
Secondary Detection of antibodies of enterovirus Detection of IgG antibodies of enterovirus 42 days